CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.COVID-19 impact on flavonoid market
3.5.Value chain Analysis
3.7.Top Impacting Factor
3.8.Parent Market Analysis
3.9.Market dynamics

3.9.1.Drivers

3.9.1.1.Rising adoption of flavonoid in nutraceuticals industry
Flavonoid is largely used in the nutraceuticals industry. This is attributed to the high consumption and demand for nutraceutical supplements containing flavonoid such as isoflavones and anthocyanidins. Flavonoid as a dietary supplement is available in various formats that include capsules, liquid, and chewable tablets. Flavonoid helps to prevent or treat certain heart conditions, diabetes, treat viral infection and other medical conditions. Thus, the aforementioned factors have driven the adoption of flavonoid such as anthocyanidins and isoflavones  in the nutraceutical industry in terms of value sales. This in turn his propelling the growth of the overall flavonoid market globally.
3.9.1.2.Rising usage of flavonoid in pharmaceutical industry
3.9.1.3.Growing usage of flavonoid in cosmetic industry

3.9.2.Restraints

3.9.2.1.Lack of consumer awareness regarding availability of flavonoid as a dietary supplement
3.9.2.2.Potential threat of substitution

3.9.3.Opportunities

3.9.3.1.Upsurge in the usage of flavonoid in the Food Industry
3.9.3.2.Introduction of dietary supplements in untapped market

CHAPTER 4:FLAVONOID MARKET, BY PRODUCT TYP

4.1.Overview

4.1.1.Market size and forecast

4.2.Isoflavones

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Anthocyanidins

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Others

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:FLAVONOID MARKET, BY FORM

5.1.Overview

5.1.1.Market size and forecast

5.3.Powder

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country

5.4.Liquid

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country

CHAPTER 6:FLAVONOID MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Cosmetics

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market analysis, by country

6.3.Pharmaceuticals

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country

6.4.Nutraceuticals

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.4.3.Market analysis, by country

6.5.Food & Beverages

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.5.3.Market analysis, by country

CHAPTER 7:FLAVONOID MARKET , BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by product type
7.2.3.Market size and forecast, by form
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.Market size and forecast, by product type
7.2.5.1.2.Market size and forecast, by form
7.2.5.1.3.Market size and forecast, by application

7.2.5.2.Mexico

7.2.5.2.1.Market size and forecast, by product type
7.2.5.2.2.Market size and forecast, by form
7.2.5.2.3.Market size and forecast, by application

7.2.5.3.Canada

7.2.5.3.1.Market size and forecast, by product type
7.2.5.3.2.Market size and forecast, by form
7.2.5.3.3.Market size and forecast, by application

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by product type
7.3.3.Market size and forecast, by form
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Market size and forecast, by product type
7.3.5.1.2.Market size and forecast, by form
7.3.5.1.3.Market size and forecast, by application

7.3.5.2.UK

7.3.5.2.1.Market size and forecast, by product type
7.3.5.2.2.Market size and forecast, by form
7.3.5.2.3.Market size and forecast, by application

7.3.5.3.France

7.3.5.3.1.Market size and forecast, by product type
7.3.5.3.2.Market size and forecast, by form
7.3.5.3.3.Market size and forecast, by application

7.3.5.4.Italy

7.3.5.4.1.Market size and forecast, by product type
7.3.5.4.2.Market size and forecast, by form
7.3.5.4.3.Market size and forecast, by application

7.3.5.5.Spain

7.3.5.5.1.Market size and forecast, by product type
7.3.5.5.2.Market size and forecast, by form
7.3.5.5.3.Market size and forecast, by application

7.3.5.6.Netherlands

7.3.5.6.1.Market size and forecast, by product type
7.3.5.6.2.Market size and forecast, by form
7.3.5.6.3.Market size and forecast, by application

7.3.5.7.Rest of Europe

7.3.5.7.1.Market size and forecast, by product type
7.3.5.7.2.Market size and forecast, by form
7.3.5.7.3.Market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by product type
7.4.3.Market size and forecast, by form
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country

7.4.5.1.India

7.4.5.1.1.Market size and forecast, by product type
7.4.5.1.2.Market size and forecast, by form
7.4.5.1.3.Market size and forecast, by application

7.4.5.2.Japan

7.4.5.2.1.Market size and forecast, by product type
7.4.5.2.2.Market size and forecast, by form
7.4.5.2.3.Market size and forecast, by application

7.4.5.3.China

7.4.5.3.1.Market size and forecast, by product type
7.4.5.3.2.Market size and forecast, by form
7.4.5.3.3.Market size and forecast, by application

7.4.5.5.Australia

7.4.5.5.1.Market size and forecast, by product type
7.4.5.5.2.Market size and forecast, by form
7.4.5.5.3.Market size and forecast, by application

7.4.5.6.South Korea

7.4.5.6.1.Market size and forecast, by product type
7.4.5.6.2.Market size and forecast, by form
7.4.5.6.3.Market size and forecast, by application

7.4.5.7.Rest of Asia-Pacific

7.4.5.7.1.Market size and forecast, by product type
7.4.5.7.2.Market size and forecast, by form
7.4.5.7.3.Market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by product type
7.5.3.Market size and forecast, by form
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Market size and forecast, by product type
7.5.5.1.2.Market size and forecast, by form
7.5.5.1.3.Market size and forecast, by application

7.5.5.2.Saudi Arabia

7.5.5.2.1.Market size and forecast, by product type
7.5.5.2.2.Market size and forecast, by form
7.5.5.2.3.Market size and forecast, by application

7.5.5.3.South Africa

7.5.5.3.1.Market size and forecast, by product type
7.5.5.3.2.Market size and forecast, by form
7.5.5.3.3.Market size and forecast, by application

7.5.5.4.Argentina

7.5.5.4.1.Market size and forecast, by product type
7.5.5.4.2.Market size and forecast, by form
7.5.5.4.3.Market size and forecast, by application

7.5.5.5.Rest of LAMEA

7.5.5.5.1.Market size and forecast, by product type
7.5.5.5.2.Market size and forecast, by form
7.5.5.5.3.Market size and forecast, by application

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Overview
8.2.Competitive dashboard
8.3.Competitive heat map
8.4.Product mapping
8.5.Top winning strategies
8.6.Key developments

8.6.1.Acquisition
8.6.2.Business Expansion
8.6.3.Joint venture
8.6.4.Partnership
8.6.5.Product Launch

8.7.Top Player Positioning

CHAPTER 9:COMPANY PROFILES

9.1.ARCHER DANIELS MIDLAND COMPANY

9.1.1.Company overview
9.1.2.Key executive
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.R&D expenditure
9.1.7.Business performance
9.1.8.Key strategic moves and developments

9.2.ARTEMIS INTERNATIONAL

9.2.1.Company overview
9.2.2.Key Executives
9.2.3.Company snapshot
9.2.4.Product portfolio
9.2.5.Key strategic moves and developments

9.3.BASF SE

9.3.1.Company overview
9.3.2.Key Executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business performance
9.3.7.Key strategic moves and developments

9.4.EEVIA HEALTH PLC

9.4.1.Company overview
9.4.2.Key Executives
9.4.3.Company snapshot
9.4.4.Product portfolio
9.4.5.Business performance

9.5.ENOMARK BIOTECH (ENOMARK HEALTHCARE)

9.5.1.Company overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Product portfolio

9.6.Givaudan International SA (NATUREX S.A.)

9.6.1.Company overview
9.6.2.Key executive
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio
9.6.6.R&D expenditure
9.6.7.Business performance
9.6.8.Key strategic moves and developments

9.7.INDENA S.P.A.

9.7.1.Company overview
9.7.2.Key Executives
9.7.3.Company snapshot
9.7.4.Product portfolio

9.8.NATAC

9.8.1.Company overview
9.8.2.Key Executives
9.8.3.Company snapshot
9.8.4.Product portfolio
9.8.5.Key strategic moves and developments

9.9.NEXIRA

9.9.1.Company overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Product portfolio

9.10.XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio

LIST OF TABLES

TABLE 01.FLAVONOID MARKET REVENUE, BY FLAVONOID MARKET , 2020–2030 ($ THOUSAND)
TABLE 02.ISOFLAVONES MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 03.ANTHOCYANIDINS FLAVONOID MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 04.OTHERS FLAVONOID MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 05.FLAVONOID MARKET REVENUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 06.FLAVONOID MARKET REVENUE FROM POWDER, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 07.FLAVONOID MARKET REVENUE FROM LIQUID, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 08.FLAVONOID MARKET REVENUE, BY APPLICATION 2020-2030($ THOUSAND)
TABLE 09.FLAVONOID MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 10.GLOBAL PHARMACEUTICALS FLAVONOID MARKET REVENUE, BY REGION, 2020-2030($ THOUSAND)
TABLE 11.FLAVONOID MARKET REVENUE FROM NUTRACEUTICALS, BY REGION, 2020-2030($ THOUSAND)
TABLE 12.FLAVONOID MARKET REVENUE FROM FOOD & BEVERAGES, BY REGION, 2020-2030($ THOUSAND)
TABLE 13.FLAVONOID MARKET REVENUE, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 14.NORTH AMERICA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE , 2020–2030 ($ THOUSAND)
TABLE 15.NORTH AMERICA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 16.NORTH AMERICA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 17.NORTH AMERICA FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 18.U.S. FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 19.U.S. FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 20.U.S FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 21.MEXICO FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 22.MEXICO FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 23.MEXICO FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 24.CANADA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 25.CANADA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 26.CANADA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 27.EUROPE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 28.EUROPE FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 29.EUROPE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 30.EUROPE FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 31.GERMANY FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 32.GERMANY FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 33.GERMANY FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 34.UK FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 35.UK FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 36.UK FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 37.FRANCE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 38.FRANCE FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 39.FRANCE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 40.ITALY FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 41.ITALY FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 42.ITALY FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 43.SPAIN FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 44.SPAIN FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 45.SPAIN FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 46.NETHERLANDS FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 47.NETHERLANDS FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 48.NETHERLANDS FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 49.REST OF EUROPE FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 50.REST OF EUROPE FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 51.REST OF EUROPE FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 52.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 53.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 54.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 55.ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 56.INDIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 57.INDIA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 58.INDIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 59.JAPAN FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 60.JAPAN FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 61.JAPAN FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 62.CHINA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 63.CHINA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 64.CHINA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 65.AUSTRALIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 66.AUSTRALIA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 67.AUSTRALIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 68.SOUTH KOREA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 69.SOUTH KOREA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 70.SOUTH KOREA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 71.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 72.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 73.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 74.LAMEA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 75.LAMEA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 76.LAMEA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 77.LAMEA FLAVONOID MARKET REVENUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 78.BRAZIL FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 79.BRAZIL FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 80.BRAZIL FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 81.SAUDI ARABIA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 82.SAUDI ARABIA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 83.SAUDI ARABIA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 84.SOUTH AFRICA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 85.SOUTH AFRICA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 86.SOUTH AFRICA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 87.ARGENTINA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 88.ARGENTINA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 89.ARGENTINA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 90.REST OF LAMEA FLAVONOID MARKET REVENUE, BY PRODUCT TYPE, 2020–2030 ($ THOUSAND)
TABLE 91.REST OF LAMEA FLAVONOID MARKET REVENUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 92.REST OF LAMEA FLAVONOID MARKET REVENUE, BY APPLICATION, 2020-2030($ THOUSAND)
TABLE 93.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 94.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 95.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 96.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 97.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 98.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 99.ARTEMIS INTERNATIONAL: KEY EXECUTIVES
TABLE 100.ARTEMIS INTERNATIONAL: COMPANY SNAPSHOT
TABLE 101.ARTEMIS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 102.BASF SE: KEY EXECUTIVES
TABLE 103.BASF SE: COMPANY SNAPSHOT
TABLE 104.BASF SE: OPERATING SEGMENTS
TABLE 105.BASF SE: PRODUCT PORTFOLIO
TABLE 106.BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 107.EEVIA HEALTH PLC: KEY EXECUTIVES
TABLE 108.EEVIA HEALTH PLC: COMPANY SNAPSHOT
TABLE 109.EEVIA HEALTH PLC: PRODUCT PORTFOLIO
TABLE 110.EEVIA HEALTH PLC: NET SALES, 2018–2020 ($MILLION)
TABLE 111.ENOMARK BIOTECH: KEY EXECUTIVES
TABLE 112.ENOMARK BIOTECH: COMPANY SNAPSHOT
TABLE 113.ENOMARK BIOTECH: PRODUCT PORTFOLIO
TABLE 114.GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE
TABLE 115.GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT
TABLE 116.GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS
TABLE 117.GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO
TABLE 118.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 119.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
TABLE 120.INDENA S.P.A.: KEY EXECUTIVES
TABLE 121.INDENA S.P.A.: COMPANY SNAPSHOT
TABLE 122.INDENA S.P.A.: PRODUCT PORTFOLIO
TABLE 123.NATAC: KEY EXECUTIVES
TABLE 124.NATAC: COMPANY SNAPSHOT
TABLE 125.NATAC: PRODUCT PORTFOLIO
TABLE 126.NEXIRA: KEY EXECUTIVES
TABLE 127.NEXIRA: COMPANY SNAPSHOT
TABLE 128.NEXIRA: PRODUCT PORTFOLIO
TABLE 129.XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 130.XIAN YUENSUN BIOLOGICAL TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.FLAVONOID MARKET SNAPSHOT
FIGURE 02.FLAVONOID MARKET: SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.HIGH BARGAINING POWER OF BUYER
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.HIGH THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.FLAVONOID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.FLAVONOID MARKET : TOP IMPACTING FACTOR
FIGURE 11.FLAVONOID MARKET: PARENT MARKET ANALYSIS
FIGURE 12.FLAVONOID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.FLAVONOID MARKET, BY PRODUCT TYPE, 2020 (%)
FIGURE 14.COMPARATIVE MARKET SHARE ANALYSIS OF ISOFLAVONES FLAVONOID MARKET,  BY COUNTRY,2020 AND 2030 (%)
FIGURE 15.COMPARATIVE MARKET SHARE ANALYSIS OF ANTHOCYANIDINS FLAVONOID MARKET ,  BY COUNTRY 2020 AND 2030 (%)
FIGURE 16.COMPARATIVE MARKET SHARE ANALYSIS OF OTHERS FLAVONOID MARKET ,  BY COUNTRY 2020 AND 2030 (%)
FIGURE 17.FLAVONOID MARKET, BY FORM, 2020 (%)
FIGURE 18.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM POWDER,  BY COUNTRY, 2020 AND 2030 (%)
FIGURE 19.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM LIQUID,  BY COUNTRY,2020 AND 2030 (%)
FIGURE 20.FLAVONOID MARKET, BY APPLICATION, 2020 (%)
FIGURE 21.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM COSMETICS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 22.COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF FLAVONOID MARKET FROM PHARMACEUTICALS, BY COUNTRY, 2020 AND 2030(%)
FIGURE 23.COMPARATIVE L MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM NUTRACEUTICALS,  BY COUNTRY, 2020 AND 2030(%)
FIGURE 24.COMPARATIVE MARKET SHARE ANALYSIS OF FLAVONOID MARKET REVENUE FROM FOOD & BEVERAGES, BY COUNTRY, 2020 AND 2030(%)
FIGURE 25.FLAVONOID MARKET, BY REGION, 2020 (%)
FIGURE 26.U.S. FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 27.MEXICO FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 28.CANADA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 29.GERMANY FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 30.UK FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 31.FRANCE FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 32.ITALY FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 33.SPAIN FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 34.NETHERLANDS FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 35.REST OF EUROPE FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 36.INDIA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 37.JAPAN FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 38.CHINA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 39.AUSTRALIA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 40.SOUTH KOREA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 41.REST OF ASIA-PACIFIC FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 42.BRAZIL FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 43.SAUDI ARABIA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 44.SOUTH AFRICA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 45.ARGENTINA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 46.REST OF LAMEA FLAVONOID MARKET REVENUE, 2020–2030 ($ THOUSAND)
FIGURE 47.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 50.TOP WINNING STRATEGIES, BY YEAR, 2017–2021*
FIGURE 51.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2021* (%)
FIGURE 52.TOP WINNING STRATEGIES, BY COMPANY, 2017–2021*
FIGURE 53.PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 54.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 55.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 56.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 57.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 58.BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 59.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 60.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 61.EEVIA HEALTH PLC: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 63.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 64.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY REGION, 2020 (%)

The market players have adopted key developmental strategies such as agreement and partnership to fuel the growth of the flavonoid market in terms of value sales. They also emphasize on continuous improvement in their product to keep a strong foothold in the market and to boost the demand for flavonoid in other industries including nutraceuticals industry, pharmaceutical industry, food & beverages industry and cosmetic industry.

According to the key market players, changing lifestyles and rise in concern regarding health and beauty are encouraging consumers to seek for non-invasive and effective solutions. Therefore, the manufacturers are investing in R&D activities and making continuous effort in launching new improved ingredient for nutraceuticals producers to help them in meeting the rising global demand of consumers for improved nutritional supplements. Thus, this factor promotes the use of flavonoid in the nutraceuticals industry.

The key market players in this market adopted new strategies such as improvement in the product launch, partnership, agreement and others as their key developmental strategies to fulfil the rise in demand for final product’s manufacturers.

However, the lack of consumer awareness regarding the availability of flavonoid as a dietary supplement especially in developing regions along with the health benefits associated with the consumption of flavonoid is likely to hamper the growth of the flavonoid market in the future.